biosimilars

News

Billions up for grabs as EU patent on AbbVie's Humira expire...

The patent for Humira, the world’s bestselling drug, expires in Europe today – opening the door for a host of cheaper biosimilars to hit the market.

News

Sandoz free to launch Humira biosimilar following AbbVie dea...

Novartis’ generics and biosimilars arm, Sandoz, has confirmed it is to launch its biosimilar of AbbVie’s Humira (adalimumab) in Europe this year after the two companies settled intellectual

News

Mundipharma buys Spanish biosimilars firm Cinfa Biotech

Mundipharma, a network of independent pharma companies, has bought Spanish biosimilars development company Cinfa Biotech.

News

Celltrion's Rituxan biosimilar gets glowing review ahead of ...

Reviewers from the FDA have given Celltrion’s biosimilar of Roche’s blood cancer blockbuster Rituxan a glowing report ahead of a key meeting of its advisers tomorrow.

News

Merck & Co signs biosimilars deal for US veterans

Merck & Co has signed a deal with the US Department of Veterans Affairs (VA) for its inflammatory diseases biosimilar, Renflexis, so that veterans’ care can be improved.

News

Pfizer CEO Read to step down, COO Bourla takes the helm

Pfizer’s CEO Ian Read is to step down after eight years and will be replaced on 1st January by chief operating officer Albert Bourla.

Billions up for grabs as EU patent on AbbVie's Humira expire...

Sandoz free to launch Humira biosimilar following AbbVie dea...

Mundipharma buys Spanish biosimilars firm Cinfa Biotech

Celltrion's Rituxan biosimilar gets glowing review ahead of ...

Merck & Co signs biosimilars deal for US veterans

Pfizer CEO Read to step down, COO Bourla takes the helm

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

biosimilars

Editor's Picks